The Brazil therapeutic respiratory devices market size was estimated at USD 343.74 million in 2024 and is expected to grow at a CAGR of 6.5% from 2025 to 2030. Respiratory devices are mainly used to treat conditions such as asthma and COPD. The demand for these devices increases as the patient population continues to grow. In addition, the aging population plays a significant role, as older adults are more susceptible to COPD, driving the need for respiratory devices. According to the Brazilian Institute of Geography and Statistics- IBGE estimates published in August 2024, between 2000 and 2023, the percentage of elderly individuals (60 years and older) in Brazil nearly doubled, increasing from 8.7% to 15.6%. By 2070, around 37.8% of the country's population is projected to be aged 60 and above.
Product types such as nebulizers and ventilators have many smaller to large-size competitors relative to other markets because these devices rely less on drug approvals, ultimately leading to supporting the market for further expansion. Market competitors continue to dominate through their strong relationships with physicians and the launch of new devices. For instance, according to an April 2022 news event from CAIRE Inc., the company launched two new products, namely, Companion 5 and NewLife Intensity 10 Stationary Concentrators, in Brazil in July after receiving the go-ahead from ANVISA, the Brazilian health regulatory agency.
Advancements in technology have significantly contributed to market growth. Innovations, such as portable oxygen concentrators and smart monitoring systems, have made respiratory care more efficient and user-friendly. For instance, introducing mobile-compatible devices and real-time monitoring improved patient outcomes and convenience. These technological advancements are driving the adoption of respiratory devices in both clinical and home settings, driving continued growth in the market.
The COVID-19 pandemic had a positive impact on the market to some extent. Non-essential healthcare services and procedures were postponed or canceled initially due to shelter-in-place orders. However, connected care businesses saw increased demand, which was advantageous for major industry players. For instance, Philips N.V. reported positive growth in its connected care businesses during the first half of 2020, including the ventilator portfolio. According to Philips N.V.'s 2020 annual report, despite the pandemic's overall effects on the company, it managed to grow comparable sales by 3% and produce a healthy cash flow of EUR 1.9 billion.
The degree of innovation in Brazil is high, with advancements focused on improving device portability, efficiency, and patient comfort. Companies are integrating smart technologies into respiratory devices, such as remote monitoring and AI-based diagnostics. For instance, oxygen concentrators with advanced filtration systems and mobile compatibility are gaining popularity, catering to growing home healthcare needs.
The market's merger and acquisition activities are moderate, with companies focusing on strategic partnerships and acquisitions to broaden their product portfolios and expand market reach. M&A is important in growing technological advancements, enhancing distribution channels, and strengthening market positioning. This medium level of consolidation facilitates growth and ensures healthy competition within the industry.
Regulations significantly impact the market, ensuring safety and efficacy. The National Health Surveillance Agency (ANVISA) enforces strict standards for medical devices, including respiratory equipment. For instance, all oxygen concentrators and ventilators comply with ANVISA’s safety regulations before entering the industry. These regulations drive innovation while maintaining high safety standards, contributing to market stability and growth.
Regional expansion is a high driver in the industry, as companies focus on reaching underserved areas with rising healthcare needs. The growth of chronic respiratory disease cases in Brazil's urban and rural regions boosts demand for respiratory devices. Manufacturers target local markets with tailored solutions, increasing accessibility and supporting the country's healthcare infrastructure development.
The nebulizers segment held the largest revenue share of 24.79% in 2024 due to their effectiveness in delivering medication directly to the lungs for treating respiratory conditions like asthma and COPD. The growing prevalence of these conditions and increased awareness of respiratory health drive the demand for nebulizers. In addition, the rising geriatric population and improvements in nebulizer technology, such as portable and quieter models, contribute to market growth. The rise in respiratory diseases accelerated the adoption of nebulizers, solidifying their largest revenue market share.
Capnographs is anticipated to grow at the fastest CAGR of 10.4% for the forecast period due to its crucial role in monitoring patients' carbon dioxide levels during respiratory therapy. These devices help ensure proper ventilation and detect respiratory complications in real-time, which is vital for critical care. The rise in surgeries, intensive care admissions, and respiratory conditions such as sleep apnea has driven demand. In addition, the increasing focus on patient safety and monitoring in hospitals and home healthcare settings contributes to capnograph adoption. The ongoing development of advanced, user-friendly models accelerates the growth of this segment in Brazil.
The electrostatic filtration segment dominated the market due to its efficiency in trapping airborne particles and pathogens. Electrostatic filters use charged particles to attract and capture dust, bacteria, and viruses, improving patient air quality. This technology is widely used in ventilators, oxygen concentrators, and humidifiers, enhancing device performance. The growing prevalence of respiratory diseases, increased hospitalizations, and increased awareness about infection control have driven demand for electrostatic filtration in therapeutic devices during the COVID-19 pandemic, driving market adoption.
HEPA filter held the second position in the market, as HEPA filters are used in therapeutic respiratory devices to remove and retain airborne particles. To meet CDC guidelines, therapeutic equipment must include HEPA filtration for effective air purification. The growing incidence of respiratory disorders and the modes of their transmission are key factors driving the demand for HEPA filters in these devices.
The ventilator filter segment held the largest revenue market share due to the critical role these filters play in ensuring the safety and efficacy of mechanical ventilation. With the increasing prevalence of respiratory diseases and the demand for ventilators, especially in hospitals, the need for high-quality filters is rising. These filters prevent contaminants and pathogens from entering the patient's respiratory system, improving patient outcomes. The COVID-19 pandemic increased the need for ventilators, driving demand for reliable ventilator filters. This segment's growth is supported by healthcare regulations emphasizing air quality standards in critical care settings.
The humidifier filter is expected to grow at the fastest rate from 2025 to 2030 due to the increasing need for moisture regulation in respiratory treatments. Humidifiers prevent airway drying, reduce irritation, and promote better outcomes for patients with respiratory conditions such as COPD and asthma. The rise in home healthcare and long-term respiratory care drove demand for these filters, as they enhance comfort and device efficiency. In addition, growing awareness of the importance of maintaining optimal air quality in medical devices and healthcare settings has driven the adoption of high-performance humidifier filters across Brazil.
Several key players dominate the market through a range of advanced products, including oxygen concentrators, nebulizers, and ventilators. These companies focus on offering innovative, high-quality solutions tailored to meet the increasing demand for respiratory care driven by the aging population and the rising prevalence of chronic respiratory diseases.
The following are the leading companies in the brazil therapeutic respiratory devices market. These companies collectively hold the largest market share and dictate industry trends:
In April 2022, CAIRE Inc ., a worldwide oxygen equipment manufacturer, is set to broaden its product range in Latin America this summer. The Companion 5 and NewLife Intensity 10 stationary oxygen concentrators were introduced in July following approval from the Brazilian Health Regulatory Agency (Anvisa).
Report Attribute |
Details |
Market size value in 2025 |
USD 366.38 million |
Revenue forecast in 2030 |
USD 502.71 million |
Growth rate |
CAGR of 6.5% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast data |
2025 - 2030 |
Quantitative units |
Volume in units, revenue in USD million and CAGR from 2025 to 2030 |
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered |
Product, technology, filter |
Key companies profiled |
Koninklijke Philips NV; Medtronic; Masimo; Chart Industries; Hamilton Medical; BD (Becton, Dickinson and Company); ResMed Inc.; General Electric Company (GE HealthCare); Drägerwerk AG & Co. KGaA; Fisher & Paykel Healthcare Limited |
Customization scope |
Free report customization (equivalent to up to 8 analyst’s working days) with purchase. Addition or alteration to country & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts volume & revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Brazil therapeutic respiratory devices market report based on product, technology, and filter:
Product Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)
Nebulizers
Compressor-based
Piston-based hand-held
Ultrasonic
Humidifiers
Heated
Passover
Integrated
Built-in
Standalone
Oxygen Concentrators
Fixed
Portable
Positive Airway Pressure Devices
Continuous PAP
Auto-titrating PAP
Bi-level PAP
Ventilators
Adult
Neonatal
Gas Analyzers
Capnographs
Technology Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)
Electrostatic Filtration
HEPA Filter Technology
Hollow Fiber Filtration
Microsphere Separation
Filter Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)
Nebulizer Filters
Inlet Filters
Replacement Filters
Cabinet Filters
Humidifier Filters
Wick Filters
Permanent Cleanable Filters
Mineral Absorption Pads
Demineralization Cartridges
PAP Device Filters
Ultra Fine Foam Inlet Filters
Polyester Non-Woven Fiber Filters
Acrylic & Polypropylene Fiber Filters
Oxygen Concentrator Filters
HEPA Filters
Cabinet Filters
Pre-Inlet Filters
Inlet Filters
Felt Intake Filters
Bacterial Filters
Hollow Membrane Filters
Micro Disk Filters
Ventilator Filters
Mechanical Filters
HEPA Filters
ULPA Filters
Activated Carbon Filters
Electrostatic Filters
Tribocharged Filters
Fibrillated Filters
b. The Brazil therapeutic respiratory devices market size was estimated at USD 343.74 million in 2024 and is expected to reach USD 366.38 million in 2025.
b. The Brazil therapeutic respiratory devices market is expected to grow at a compound annual growth rate of 6.53% from 2025 to 2030 to reach USD 502.71 million by 2030.
b. The nebulizers segment accounted for the highest revenue share of 24.79% in 2024, due to their effectiveness in delivering medication directly to the lungs for treating respiratory conditions like asthma and COPD.
b. Some key players operating in the Brazil therapeutic respiratory devices market include Koninklijke Philips NV, Medtronic, Masimo, Chart Industries, Hamilton Medical, BD (Becton, Dickinson and Company), ResMed Inc., General Electric Company (GE HealthCare), Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited
b. Key factors that are driving the market growth include technological advancements in respiratory devices, rising prevalence of respiratory diseases, increasing demand for home oxygen therapy, growing aging population, high tobacco consumption, and government and private initiatives.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."